Log in

CVE:MFSMedifocus Stock Price, Forecast & News

C$0.01
-0.01 (-33.33 %)
(As of 07/15/2020 08:00 AM ET)
Add
Compare
Today's Range
C$0.01
Now: C$0.01
C$0.01
50-Day Range
C$0.01
MA: C$0.01
C$0.02
52-Week Range
C$0.01
Now: C$0.01
C$0.02
Volume97,639 shs
Average Volume391,863 shs
Market CapitalizationC$1.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medifocus Inc., a medical technology company, develops and commercializes minimally invasive focused heat systems for the treatment of cancerous and benign tumors, and enlarged prostate in Canada and the United States. The company owns technology platforms, including Endo-thermotherapy platform, a catheter-based focused heat technology platform that utilizes natural body openings to deliver microwave thermotherapy to the diseased sites; and Adaptive Phased Array (APA) Microwave Focusing platform, which directs focused microwave energy at tumor center to induce shrinkage or eradication of tumors without undue harm to surrounding tissue. It also offers Prolieve Thermodilatation system, a medical device based on endo-thermotherapy for the treatment of benign prostatic hyperplasia. In addition, the company is developing APA 1000, a minimally invasive breast cancer treatment system, which is in pivotal Phase-III clinical trials. The company has a license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy technology for the treatment of cancers and other diseases. Medifocus Inc. has a patent license agreement with Duke University for the development of heat-activated and tumor-targeted immunotherapy and gene therapy for the treatment of cancers and other diseases. The company is based in Columbia, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.50 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-905-3197070

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$2.23 million
Cash FlowC$0.00 per share
Book ValueC($0.07) per share

Profitability

Miscellaneous

Employees7
Market CapC$1.85 million
Next Earnings Date9/3/2020 (Estimated)
OptionableNot Optionable

Receive MFS News and Ratings via Email

Sign-up to receive the latest news and ratings for MFS and its competitors with MarketBeat's FREE daily newsletter.

Medifocus (CVE:MFS) Frequently Asked Questions

When is Medifocus' next earnings date?

Medifocus is scheduled to release its next quarterly earnings announcement on Thursday, September 3rd 2020. View our earnings forecast for Medifocus.

Has Medifocus been receiving favorable news coverage?

Media stories about MFS stock have trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Medifocus earned a news sentiment score of -1.1 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Medifocus.

Who are some of Medifocus' key competitors?

What other stocks do shareholders of Medifocus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifocus investors own include Relypsa (RLYP), Sangamo Therapeutics (SGMO), Regeneron Pharmaceuticals (REGN), Onconova Therapeutics (ONTX), Intec Pharma (NTEC), FireEye (FEYE), Chevron (CVX), BP Prudhoe Bay Royalty Trust (BPT) and Axon Enterprise (AAXN).

Who are Medifocus' key executives?

Medifocus' management team includes the following people:
  • Dr. William W. Jow, CEO, Pres & Director (Age 61)
  • Mr. Mirsad Jakubovic C.A., M.B.A., Chief Financial Officer (Age 57)
  • Mr. John Mon, VP of Regulatory Affairs & Product Devel. (Age 66)
  • Mr. Douglas Liu, VP of Fin. (Age 55)
  • Dr. Stuart E. Katz M.D., VP of Operations

What is Medifocus' stock symbol?

Medifocus trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MFS."

How do I buy shares of Medifocus?

Shares of MFS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Medifocus' stock price today?

One share of MFS stock can currently be purchased for approximately C$0.01.

How big of a company is Medifocus?

Medifocus has a market capitalization of C$1.85 million and generates C$2.23 million in revenue each year. Medifocus employs 7 workers across the globe.

What is Medifocus' official website?

The official website for Medifocus is www.medifocusinc.com.

How can I contact Medifocus?

Medifocus' mailing address is The Exchange Tower Suite 1800, 130 King Street West, PO Box 427, TORONTO, ON M5X 1E3, Canada. The company can be reached via phone at +1-905-3197070.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.